Scope Diagnostics

SUMMARY
We are a biotech startup in NE, Ohio, looking for an angel investor to fund our preliminary studies for an over-the-counter diagnostic test (a biosensor) for early-stage Lyme disease.

HIGHLIGHTS
Over the Counter Test, Run Time 15 mins, Principle Investigator for PoC at an accredited institution, working towards FDA clearance, provisional patent.

Want to see a pitch deck? Send me your email! 

BUSINESS
This biosensor is designed to be an over-the-counter diagnostic test for the early detection of Lyme disease using a specific biomarker and a very sensitive electrochemical technique. The test can be performed entirely out of the lab; the test requires a small volume size collection and can be completed within 15 mins by anyone, anywhere, and anytime. The goal is to commercialize our test at a competitive price and expand in retail outlets.

Although the platform is designed to test early-stage Lyme, it can expand to other diseases like cervical, breast, prostate cancer, infectious diseases, neurological diseases like Parkinson's, and even food-borne pathogens, using various biorecognition elements like aptamers and antibodies. 

MARKET
Fantastic market opportunity. The OTC diagnostics total addressable market is 40-45B per year (World Health Organization), while the US addressable market (or SOM) is 13.8B USD.
Lyme disease is also booming. The total addressable market for Lyme disease diagnostics is 2.5B, while the US market is around 880M USD.

PROOF AND PROGRESS
Progress: laboratory space, protocol, reagents and materials, and consulting experts on stand-by, all ready to go; we only need a round of investment to pull the trigger.
Proof: Consulting with multiple experts (all doctorates) in the biosensor, infectious disease, and electrochemistry industries and over four dozen publications showing the technique works. Talks with the manufacturer are in place, and a large scale is possible.

FUTURE OBJECTIVES
Objectives: With your help, launch our prelim study, which should last about four months.
Near future objectives: Launch our Proof-of-Concept with a well-known academic institution, hire postdocs and lab assistants, and test the sensitivity and selectivity of the test. Then move right into FDA clearance, non-provisional patenting, and a commercialization strategy.

THE TEAM
The company is a woman-owned startup by a graduate with a degree in biochemistry and molecular biology. The college was recently listed as #8 in the nation for undergraduate research, right after Stanford University, and #1 for mentored undergraduate research, before Princeton University. We also have an affiliation with two well-known institutions, which I will reveal if you plan on investing, and a postdoc committed to helping this winter. We are also affiliated with a local business incubator.

A NOTE FROM THE CEO
I started the company earlier this year because my friend was misdiagnosed with colitis and passed away in 2018 due to complications with her prescription meds. Her autopsy report showed gastrointestinal Lyme disease. Over the past year and a half, I have used my biochemistry and molecular biology background to research a better way to diagnose Lyme disease extensively. I have regularly consulted with an emeritus professor of Chemistry, an Immunology and Lyme disease expert, and a biosensor expert from accredited institutions. We are also actively seeking a postdoc to help with the workload in our prelim study. Please join me as we pave a new path in the biotech industry together.